Literature DB >> 11507244

Phenobarbital, oxazepam and Wyeth 14,643 cause DNA damage as measured by the Comet assay.

W A Deutsch1, A Kukreja, B Shane, V Hegde.   

Abstract

Although phenobarbital, oxazepam and Wyeth 14,643 are carcinogens that do not form DNA adducts, they induce mutations in the Big Blue transgenic mouse model. The mutations produced by these compounds were predominantly G-->T and G-->C transversions that we suspect arose from oxidative damage to DNA. To test this, we employed the single cell electrophoresis (Comet) assay that detects alkali-labile lesions in cells sustaining DNA damage. Human myeloid leukemia K562 cells were treated with non-cytotoxic doses of the above compounds for 3 h, then placed on slides containing low melting point agarose. Cells were lysed, exposed to alkaline buffer, electrophoresed and analyzed by microscopy for the existence of DNA damage. Extensive DNA damage, most likely due to the existence of single- and double-strand breaks and apurinic/apyrimidinic (AP) sites, was observed in cells exposed to oxazepam (1 mM) and Wyeth 14,643 (0.5 mM). On the other hand, damage of this sort was not observed in cells exposed to phenobarbital (1 mM). However, the addition of S9 liver extracts to cells exposed in the presence of phenobarbital resulted in significant amounts of DNA damage. We conclude from these studies that two of the three compounds evaluated in this study mediate their mutagenic effects through oxidative stress, but that the mechanism of DNA damage caused by phenobarbital differs from that elicited by oxazepam and Wyeth 14,643.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11507244     DOI: 10.1093/mutage/16.5.439

Source DB:  PubMed          Journal:  Mutagenesis        ISSN: 0267-8357            Impact factor:   3.000


  9 in total

1.  Aging, resting metabolic rate, and oxidative damage: results from the Louisiana Healthy Aging Study.

Authors:  Madlyn I Frisard; Amanda Broussard; Sean S Davies; L Jackson Roberts; Jennifer Rood; Lillian de Jonge; Xiaobing Fang; S Michal Jazwinski; Walter A Deutsch; Eric Ravussin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2007-07       Impact factor: 6.053

2.  Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial.

Authors:  Leonie K Heilbronn; Lilian de Jonge; Madlyn I Frisard; James P DeLany; D Enette Larson-Meyer; Jennifer Rood; Tuong Nguyen; Corby K Martin; Julia Volaufova; Marlene M Most; Frank L Greenway; Steven R Smith; Walter A Deutsch; Donald A Williamson; Eric Ravussin
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

3.  DNA repair efficiency in transgenic mice over expressing ribosomal protein S3.

Authors:  Vijay Hegde; Sridevi Yadavilli; Leslie D McLaughlin; Walter A Deutsch
Journal:  Mutat Res       Date:  2009-03-27       Impact factor: 2.433

4.  Metabolic syndrome and risk factors for cardiovascular disease: are nonagenarians protected?

Authors:  Madlyn I Frisard; Jennifer C Rood; Xiaobing Fang; Joseph Su; David A Welsh; S Michal Jazwinski; Eric Ravussin
Journal:  Age (Dordr)       Date:  2009-01-31

5.  Mutagenicity of the peroxisome proliferators clofibrate, Wyeth 14,643 and di-2-ethylhexyl phthalate in the lacZ plasmid-based transgenic mouse mutation assay.

Authors:  Michaël ETI Boerrigter
Journal:  J Carcinog       Date:  2004-05-05

6.  A toxicogenomic approach for the prediction of murine hepatocarcinogenesis using ensemble feature selection.

Authors:  Johannes Eichner; Nadine Kossler; Clemens Wrzodek; Arno Kalkuhl; Dorthe Bach Toft; Nina Ostenfeldt; Virgile Richard; Andreas Zell
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

7.  Cross-platform toxicogenomics for the prediction of non-genotoxic hepatocarcinogenesis in rat.

Authors:  Michael Römer; Johannes Eichner; Ute Metzger; Markus F Templin; Simon Plummer; Heidrun Ellinger-Ziegelbauer; Andreas Zell
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

8.  Data mining reveals a network of early-response genes as a consensus signature of drug-induced in vitro and in vivo toxicity.

Authors:  J D Zhang; N Berntenis; A Roth; M Ebeling
Journal:  Pharmacogenomics J       Date:  2013-11-12       Impact factor: 3.550

9.  Evaluation of toxicogenomics approaches for assessing the risk of nongenotoxic carcinogenicity in rat liver.

Authors:  Johannes Eichner; Clemens Wrzodek; Michael Römer; Heidrun Ellinger-Ziegelbauer; Andreas Zell
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.